gefitinib has been researched along with Degenerative Disc Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bunpetch, V; Fu, Q; Heng, BC; Hu, W; Li, J; Ouyang, H; Pan, Z; Shen, W; Sun, H; Wang, Y; Wang, Z; Wu, Y; Xia, D; Xie, B; Xu, Y; Yang, Y; Yu, D; Zhang, S; Zhang, X | 1 |
1 other study(ies) available for gefitinib and Degenerative Disc Disease
| Article | Year |
|---|---|
Therapeutic effects of gefitinib-encapsulated thermosensitive injectable hydrogel in intervertebral disc degeneration.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Drug Carriers; ErbB Receptors; Gefitinib; Humans; Hydrogels; Intervertebral Disc Degeneration; Lung Neoplasms; Mice; Protein Kinase Inhibitors; Rats | 2018 |